Clinical Oncology
Volume 22, Issue 7 , Pages 588-589 , September 2010

Late Complications from Chemoradiotherapy for Cervical Cancer: Reflections from Cervical Cancer Survivors 10 Years after the National Cancer Institute Alert

  • C. Vale

      Affiliations

    • Corresponding Author Information Meta-analysis Group, Medical Research Council Clinical Trials Unit, London, UK
    • Corresponding Author InformationAuthor for correspondence: C. Vale, Meta-analysis Group, Medical Research Council Clinical Trials Unit, 222 Euston Road, London, UK. Tel: +44-(0)20-7670-4723; Fax: +44-(0)20-7670-4816.
  • ,
  • A. Nightingale

      Affiliations

    • Cervical Cancer Patient Research Partners, Meta-analysis Group, Medical Research Council Clinical Trials Unit, London, UK
  • ,
  • N. Spera

      Affiliations

    • Cervical Cancer Patient Research Partners, Meta-analysis Group, Medical Research Council Clinical Trials Unit, London, UK
  • ,
  • A. Whelan

      Affiliations

    • Cervical Cancer Patient Research Partners, Meta-analysis Group, Medical Research Council Clinical Trials Unit, London, UK
  • ,
  • B. Hanley

      Affiliations

    • TwoCan Associates, Hove, UK
  • ,
  • J.F. Tierney

      Affiliations

    • Corresponding Author Information Meta-analysis Group, Medical Research Council Clinical Trials Unit, London, UK

Received 1 April 2010 ,Revised 22 April 2010 ,Accepted 12 May 2010.

References 

  1. National Cancer Institute . NCI issues clinical announcement on cervical cancer: chemotherapy plus radiation improves survival. 1999;
  2. Goonatillake S, Khong R, Hoskin P. Chemoradiation in gynaecological cancer. Clin Oncol. 2009;21(7):566–572
  3. Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol. 2008;26(35):5802–5812
  4. Vale CL, Tierney JF, Davidson SE, Drinkwater KJ, Symonds P. Substantial improvement in UK cervical cancer survival with chemoradiotherapy: results of a Royal College of Radiologists’ audit. Clin Oncol, in this issue.
  5. Davidson SE, Trotti A, Ataman OU, et al. Improving the capture of adverse event data in clinical trials: the role of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys. 2007;69:1218–1221

PII: S0936-6555(10)00189-5

doi: 10.1016/j.clon.2010.05.017

Clinical Oncology
Volume 22, Issue 7 , Pages 588-589 , September 2010